GABA Biomarkers in Dravet Syndrome
NCT05651204
This study is recruiting at 1 US site in 1 state, according to its ClinicalTrials.gov record last updated .
Summary
This study will non-invasively obtain levels of GABA in the brain of children with SCN1A+DS and neurodeveloping children through evoked and induced cortical responses, correlate them with the BOLD responses, and with the levels of GABA in their blood.
Shortened from the sponsor's brief summary. View official record on ClinicalTrials.gov
Conditions studied
- Dravet Syndrome
Eligibility basics and study details
- Study type
- Observational
- Phase
- Not applicable
- Ages
- Up to 18 years
- Sex
- All
- Healthy volunteers
- Accepted
- Sponsor
- Cook Children's Health Care System
- Last updated on ClinicalTrials.gov
- December 14, 2022
These are the basic criteria only. The full inclusion and exclusion criteria are on the official record, and the study team decides who can take part.
US recruiting sites
Texas · 1
- Cook Children's Medical Center · Fort Worth, TX
Source: ClinicalTrials.gov, data processed . Recruiting US sites filtered by distance and site status; summaries shortened.